Nystatin2 is one of a group of polyene antifungal antibiotics discovered in recent years (Hazen and Brown, 1951; Oroshnick et al., 1955) . It contains a conjugated tetraene grouping and a diene unit, a carbonyl and a primary amino group, and has a molecular weight of approximately 950 (Dutcher et al., 1955) . Nystatin inhibits the growth of most fungi at concentrations between 1 and 10 jig per ml, but shows no activity against actinomyces, bacteria, rickettsiae, or animal cells. It is more effective against vegetative cells than against spores. Its antifungal action is not prevented by casein hydrolyzate or yeast extracts, nor is it affected by pH over a fairly wide range. Its activity is reduced in 0.01 M cysteine solution (Donovick et al., 1955) and in 30 per cent plasma (Pagano and Stander, 1955) . Its action appears to be primarily fungicidal and irreversible. The development of organisms resistant to high concentrations of nystatin has not been observed either in clinical use or in laboratory studies. It has, however, been possible to obtain from a few fungi mutants for which the growth inhibiting concentration of nystatin is several times that required for the original strains Pagano, 1955-1956) .
Dr. Harlyn 0. Halvorson observed that the aerobic and anaerobic utilization of glucose and maltose by Saccharomyces cerevisiae was inhibited in the presence of low concentrations of nystatin. The experiments presented here represent an extension of this initial observation.
METHODS AND MATERIALS
Manometric studies were carried out at 30 C in standard 15 ml Warburg vessels using a reaction volume of 3.0 ml. For measurement of oxygen uptake the gas phase was air; carbon 1 A preliminary report on a part of this study has been presented (Lampen et al., 1956 (Dutcher et al., 1955) was used throughout this study. Nystatin solutions were prepared by dissolving 10 to 100 mg in 10 ml of dimethyl sulfoxide followed by dilution with water to 100 ml. Of these solutions, 0.1 to 0.2 ml were added to the test mixture so that the final concentration of dimethyl sulfoxide was 0.3 to 0.7 per cent. A final concentration of 1 per cent dimethyl sulfoxide had no significant effect on sugar metabolism by the various organisms studied. In pH 4.5 succinate-phosphate buffer containing 1 per cent dimethyl sulfoxide, nystatin is stable for 2 to 3 days at 4 C and for 12 to 24 hr at 30 C. Measurement for residual glucose as reducing sugar was made on bariumzinc filtrates by the method of Nelson (1944) .
The microorganisms used in these studies were Penicillium chrysogenum (Q176), Streptococcus faecalis (lOC1), Escherichia coli (ATCC 9723), Candida albicans strain R (nystatin resistant, Squibb 2678), Candida albicans strain S (nystatin sensitive, Squibb 2680), Torula lactosa (211) 1. Endogenous oxygen consumption and aerobic and anaerobic utilization of glucose by S. cerevisiae were inhibited by concentrations of nystatin approximating those necessary to inhibit growth. With P. chrysogenum glucose oxidation and endogenous respiration had essentially the same sensitivity as did growth. At a given concentration of nystatin the inhibition of glucose oxidation by the "resistant" strain of C. albicans was less than that observed with the "sensitive" strain. This correlates with the sensitivity of growth of the two strains to nystatin.
E. coli and S. faecalis are two organisms whose growth is not inhibited by nystatin. As indicated in table 1, high concentrations of nystatin had little or no effect on glycolysis or glucose oxidation by these organisms. The production of acid and gas and the utilization of glucose were not affected by nystatin concentrations many times those required to inhibit yeast under identical conditions.
With the limited yet representative series of organisms studied, there appears, therefore, to be a general correlation between the sensitivity of the growth of the organism and of its utilization of glucose.
The effect of nystatin on glucose oxidation by S. cerevisiae (F) is illustrated in greater detail in figure 1A . With 10 ,gg of nystatin per ml there was an initial stimulation of oxygen uptake followed by a rapid loss of activity. In the presence of 2.7 Ag/ml the rate closely approximated the control rate for 20 min and then rapidly declined. Oxidation in the presence of 0.4 ,ug of nystatin per ml appeared normal over the first 60 min. Following this the rate was higher in the presence of nystatin than in its absence. At 170 min 43 umoles of oxygen had been utilized in the presence of nystatin as compared to 35 ,imoles in the control. There was no stimulation or inhibition at 0.2 ,ug/ml. Incubation of the cells with nystatin prior to glucose addition prevented oxidation completely.
The action of nystatin on glycolysis as with oxidation is characterized by an initial burst of metabolic activity followed quickly by a cessation of glucose utilization. sitive to nystatin than is oxidation. This is obvious from the curves at 3.3 ug/ml in figures 1A and 1B.
The initial stimulation with high levels of nystatin and the increased total oxygen uptake with low levels are suggestive of the action of uncoupling agents such as dinitrophenol (Hunter, 1951) . Since oxygen uptake and glycolysis are eventually completely prevented, the action of nystatin is not, however, entirely analogous.
Endogenous respiration by S. cerevisiae strains F and A-B was characterized by an R.Q. of 1.0 to 1.1 and probably represents primarily carbohydrate utilization. This endogenous respiration was eliminated in the presence of 2.5 ,ug of nystatin per ml.
Under the conditions used in the manometric studies, namely, a cell concentration of 0.83 mg (dry wt) per ml in pH 4.5 succinate-phosphate buffer at 30 C, 67 per cent of the yeast cells were killed by 8 ,ug of nystatin per ml in 10 min and 95 per cent in 30 min. Thus, loss of viability and of metabolic activity are essentially coincident. Visible effects of nystatin on yeast cells, as determined by electron microscopy, occurred only after exposure for 24 hr at 37 C to 100 Mg or more of nystatin per ml (Coy et al., unpublished data) . After this treatment the cells of C. albicans appeared more transparent and there was a definite recession of the protoplasm from the cell wall.
No reversal or prevention of the action of nystatin on yeast was obtained by the addition of adenosinetriphosphate, diphosphopyridinenucleotide, adenosine-5'-phosphate, and diphosphothiamin. Cells of S. cerevisiae exposed for 10 min to 12 Mug of nystatin per mg of cells and repeatedly washed in the pH 4.5 buffer did not regain glycolytic activity. It has been observed that at this concentration 0.22 Mug of nystatin is absorbed per mg of cells and is not eluted by repeated washing with buffer. A boiled yeast extract in an amount equivalent in protein to 0.83 mg of fresh cells per ml prevented but did not reverse the action of nystatin. These data on nystatin absorption by fresh cells and binding by boiled yeast extracts will be published in detail (Lampen et al., unpublished data) . Hickey (1953) observed that the antifungal activity of ascosin (a polyene antibiotic) is lowered in the presence of the unsaturated fatty acids oleic and linoleic. Donovick et al. (1955) reported that nystatin is affected similarly but to a lesser degree than ascosin. In our studies there was no change in the degree .of inhibition of glycolysis by 2.5 Mg of nystatin per ml when sodium linoleate was added in amounts ranging from 50 to 300 ,ug/ml.
Yeast cells (strain F) exposed for 30 min to excess nystatin (10 Mug/mg of cells) did not metabolize glucose which was added subsequently (figure 1). No ketose was formed nor did the reducing sugar value change during incubation for 60 min. At this time the reducing sugar could still be completely removed by treatment with glucose oxidase.
It appears that nystatin renders the cell incapable of utilizing glucose, but does not block the penetration of glucose through the cell wall. This was demonstrated by measuring the fraction of the total water in a concentrated yeast suspension that was in rapid equilibrium with glucose (Roberts et al., 1955) Effect of pH. Figure 2 shows the effect of pH on the inhibition of yeast glycolysis by nystatin. The control curve at pH 4.5 is representative of those obtained at pH 6.5 and 7.8 as well. A concentration of 3.3 ,ug of nystatin per ml is sufficient at pH 4.5 to inhibit glycolysis almost completely within 20 min. This concentration had no detectable effect at pH 6.5 or 7.5. At 8.3 ,ug/ml a definite inhibition was obtained at the higher pH values, although the lag was greater and the degree of inhibition less. Incubation of the cells in the presence of 8.3 ,ug/ml for 1 hr prior to glucose addition caused a more pronounced inhibition which never reached that produced at pH 4.5. A similar effect was obtained by increasing the nystatin concentration to 16.5 ,ug/ml (figure 2).
No evidence could be obtained that nystatin undergoes activation at pH 4.5. A sample of nystatin incubated in the pH 4.5 buffer for 30 min and then added to cell suspensions at pH 4.5 and 6.8 produced an inhibition of glycolysis equivalent to that observed with an untreated sample. In a second experiment cells were incubated for 60 min in pH 6.8 phosphate buffer containing 8.3 ,ug of nystatin per ml. After the addition of 60 Mmoles of glucose, these cells liberated 302 ,uL of CO2 in 60 min. Control cells liberated 813 ,uL of CO2 in this period. An aliquot of the cell suspension pre-exposed at pH 6.8 was centrifuged, washed, and resuspended in pH 4.5 succinate-phosphate buffer containing 60 ,umoles of glucose. It showed no detectable glycolytic activity. Cells incubated at pH 4.5 with 8.3 ,g nystatin per ml for 60 min and then washed and resuspended at pH 6.8 in the presence of glucose were also inactive. Thus, nystatin appears to cause rapid metabolic changes at pH 4.5, whereas the change at pH 6.8 is slower.
Effect of nystatin on substrates other than glucose. Nystatin at low concentrations blocks the utilization (aerobic or anaerobic) of galactose by T. lactosa, of ethanol by R. glutinis, and of ribose, xylose, and arabinose by D. guilliermondii (table   2) . These findings are additional evidence that Compounds related to nystatin. The effect of antifungal agents other than nystatin on glucose utilization by S. cerevisiae was studied. The polyene antifungals amphotericin A and B strongly inhibited glycolysis at concentrations of 2 to 3 Ag/ml and oxidation at 5 to 10 ,ug/rnl.
Of the non-polyenes, actidione (Whiffen, 1948) had no effect on glycolysis at 300 ,ug/ml. Pyridinethione was active only at 30 ,ug/ml, whereas the growth of S. cerevisiae is inhibited in the presence of 0.08 ,ug per ml (Pansy et al., 1953) .
Perhydronystatin and samples of nystatin whose growth inhibiting activity was destroyed by mild treatment with 0.1 N KOH or HCl (Dutcher et al., 1955) did not prevent glycolysis at a concentration of 100 ,ug/ml.
DISCUSSION
The results presented here indicate that the effect of nystatin on the metabolism of various substrates bears a direct relation to the process by which growth of the cells is inhibited. Thus, there appears to be an excellent correlation with various organisms studied between the sensitivity to nystatin of growth and of substrate utilization. Also the concentration of nystatin required to inhibit glucose metabolism by a given strain approximates that necessary to inhibit growth. The increased resistance of glycolysis observed with the R strain of C. albicans is particularly interesting in this respect. The data on the relation of structure to activity in the two tests are extremely limited, but are consistent with the hypothesis that the same structure is essential for both phenomena. In addition, the action of nystatin appears essentially irreversible in both systems.
There is an apparent contradiction in the effect of pH on the two phenomena. The mechanism of the inhibitory action of nystatin on the utilization of endogenous and exogenous substrates cannot be clearly defined at present. The initial stimulation of oxidation or glycolysis noted with high concentrations and the increased oxygen consumption at subinhibitory concentrations suggest an effect on a factor whose concentration is rate controlling. The subsequent rapid loss of metabolic activity essentially coincident with a loss of viability indicate a critical importance of this factor for the cell.
Since endogenous respiration is highly sensitive, and the cell volume in rapid equilibrium with extracellular glucose is essentially identical in normal cells and in those treated with excess nystatin, nystatin does not appear to act by altering the permeability of the cell to substrates.
It has not been possible thus far to prepare soluble enzyme preparations from yeast whose glycolytic action is inhibited by nystatin. It is known, however, that large amounts of materials binding nystatin are present in extracts of sensitive cells (Lampen et al., unpublished data 
